Celltrion Healthcare is a global biopharmaceutical company committed to delivering affordable quality therapeutics for patients. Access to advanced yet costly therapeutics is often a challenge to patients and healthcare providers. In particular, biologics have become an increasingly important but also expensive part of the global medicine cabinet. We believe that every patient deserves access to treatments they need. Based on this belief, Celltrion Healthcare has been steadfast in our mission to meet the needs of patients who previously had limited access to advanced therapeutics since our inception in 1999 by developing biosimilar products. As a result, our biosimilar products approved in over 90 countries and already prescribed in majority of these approved countries.